Inmune Bio (INMB) Payables (2017 - 2026)
Inmune Bio's Payables came in at $5.05 million for Q2 2026, down 34.1% from $7.67 million a year earlier but up 8.5% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Inmune Bio's Payables was $7.77 million, up 18.8% from FY2024.
- Payables carries a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
- Going back by year, Payables was $6.54 million in FY2024 (-17.2%), $7.9 million in FY2023 (+51.8%), $5.21 million in FY2022 (+39.5%) and $3.73 million in FY2021 (+145.9%).
- The five-year range for quarterly Payables is $1.69 million (Q2 2022) to $10.59 million (Q3 2024).
- Year-over-year, Payables increased in two of the last eight quarters, with growth averaging 5.7%.
- The fastest year-over-year change in Payables over five years came in Q1 2024 (growth of 347.5%), and the weakest in Q1 2026 (a decline of 35.3%).
- Business Quant data shows INMB's Payables at $4.66 million (Q1 2026), $7.77 million (Q4 2025) and $6.88 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Inmune Bio | 55.31 Mn | -36.95 Mn | - | 5.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.05 Mn |
| Mar 31, 2026 | 4.66 Mn |
| Dec 31, 2025 | 7.77 Mn |
| Sep 30, 2025 | 6.88 Mn |
| Jun 30, 2025 | 7.67 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 6.54 Mn |
| Sep 30, 2024 | 10.59 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 9.29 Mn |
| Dec 31, 2023 | 7.90 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 2.39 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Sep 30, 2022 | 3.47 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 3.73 Mn |
| Sep 30, 2021 | 4.22 Mn |
API Access
Inmune Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();